Home/Pipeline/IBI188

IBI188

Solid tumors

Phase 1Active

Key Facts

Indication

Solid tumors

Phase

Phase 1

Status

Active

Company

Innovent Biologics

About Innovent Biologics

Innovent Biologics is one of China's premier biotechnology companies, established in 2011 and publicly traded on the Hong Kong Stock Exchange. The company specializes in developing innovative biologics for oncology, autoimmune, and metabolic diseases, with a strong focus on monoclonal antibodies and bispecific antibodies. Innovent has successfully commercialized multiple products in China and has strategic partnerships with global pharmaceutical companies including Eli Lilly and Roche.

View full company profile

Therapeutic Areas

Oncology Autoimmune Hematology

Other Solid tumors Drugs

Drug	Company	Phase	Status
GSK4362676	GSK plc	Phase 1	Active
ABBV-154	AbbVie	Phase 1	Active
TAK-981	Takeda Pharmaceutical	Phase 1/2	Active
TAK-676	Takeda Pharmaceutical	Phase 1	Active
TAK-573	Takeda Pharmaceutical	Phase 1	Active
TAK-164	Takeda Pharmaceutical	Phase 1	Active
SHR-1316	Jiangsu Hengrui Medicine	Phase 1/2	Active
BAY 2927088	Bayer	Phase 1	Active
ASP1929	Astellas Pharma	Phase 2	Active
Bispecific Antibody	Akeso	Phase 1/2	Active
CSPC-DM02	CSPC Pharmaceutical Group Limited	Phase 2	Active
ONO-4538 combinations	Ono Pharmaceutical	Phase 2	Active